Gabrielle DeGravina | Investor Relations, CG Capital |
Frank Bedu-Addo | Chief Executive Officer |
Lauren Wood | Chief Medical Officer |
Matthew Hill | Chief Financial Officer |
Leland Gershell | Oppenheimer & Co. |
Louise Chen | Cantor Fitzgerald |
Andrew Fleszar | B. Riley Securities |
James Molloy | Alliance Global Partners |
Robert LeBoyer | Noble Capital Markets |
Greetings. Welcome to PDS Biotechnology Fourth Quarter 2022 and Full-Year Earnings Conference Call. [Operator Instructions]. A question-and-answer session will follow the formal presentation.
As a reminder, this conference is being recorded.